Aktien Sensor

Essity AB has released preliminary Q2 2025 earnings estimates, expecting a 0.21% profit increase to 4.74 SEK per share.

Essity AB’s stock price has remained relatively stable amidst geopolitical uncertainty, with a 0.8% increase on June 30, despite a 5.5% surge in a US competitor’s stock.

Despite recent stock price fluctuations, Essity AB’s strong fundamentals and potential for growth make it a compelling investment opportunity.

Essity AB is set to release its Q2 interim report on July 17, amidst ongoing litigation with obligations holders and a continued share buyback program.

Essity AB’s stock price has taken a 2.2% hit, but its long-term prospects remain intact, with a stable market capitalization and positive outlook.

Essity AB is poised for growth as it capitalizes on industry trends, including the rising demand for compression therapy products and menstrual health solutions.

Essity AB appoints Ulrika Kolsrud as its new president and CEO, marking a new chapter for the company with renewed leadership and confidence.

Essity AB appoints Ulrika Kolsrud as President and CEO, effective June 1st, marking a new era for the company with a focus on growth, innovation, and customer satisfaction.

Essity AB reports strong Q1 2025 earnings, initiates a SEK 3 billion share buyback program, and participates in the World Hand Hygiene Day initiative with its TORK brand.

Essity’s 2025 Annual General Meeting approved the company’s 2024 income statement and balance sheet, as well as a dividend of SEK 8.25 per share.